0001209191-23-036798.txt : 20230613 0001209191-23-036798.hdr.sgml : 20230613 20230613170021 ACCESSION NUMBER: 0001209191-23-036798 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230609 FILED AS OF DATE: 20230613 DATE AS OF CHANGE: 20230613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sharp Shalini CENTRAL INDEX KEY: 0001377202 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40235 FILM NUMBER: 231012008 MAIL ADDRESS: STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC. STREET 2: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Organon & Co. CENTRAL INDEX KEY: 0001821825 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464838035 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 HUDSON STREET STREET 2: FL 33 CITY: JERSEY CITY STATE: NJ ZIP: 07302 BUSINESS PHONE: 551-430-6000 MAIL ADDRESS: STREET 1: 30 HUDSON STREET STREET 2: FL 33 CITY: JERSEY CITY STATE: NJ ZIP: 07302 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-09 0 0001821825 Organon & Co. OGN 0001377202 Sharp Shalini C/O ORGANON & CO. 30 HUDSON STREET, FLOOR 33 JERSEY CITY NJ 07302 1 0 0 0 0 Common Stock 2 D Phantom Stock 2023-06-09 4 A 0 10086 19.83 A Common Stock 10086 25594 D Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1. Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan. Holdings include phantom stock acquired in dividend reinvestment transactions on June 16, 2022, September 15, 2022, December 15, 2022 and March 16, 2023. /s/ Tarnetta V. Jones, as Attorney-in-Fact for Shalini Sharp 2023-06-13